Asset Management One
SCMP

Asset Management One’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Asset Management One’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-48,532
Closed -$532K – 1375
2016
Q2 		$532K Sell
48,532
-39,750
-45% -$445K 0.01% 1037
2016
Q1 		$965K Hold
88,282
– – 0.01% 873
2015
Q4 		$1.53M Hold
88,282
– – 0.02% 718
2015
Q3 		$1.75M Buy
88,282
+78,152
+771% +$1.79M 0.03% 667
2015
Q2 		$166K Hold
10,130
– – ﹤0.01% 1266
2015
Q1 		$158K Hold
10,130
– – ﹤0.01% 1274
2014
Q4 		$145K Buy
+10,130
New +$107K ﹤0.01% 1213

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Asset Management One's SCMP Position: Q3 2016 in Review

Asset Management One sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2016, closing a stake of 48,532 shares — an estimated $532K sold.

Asset Management One first reported a position in SCMP in Q4 2014 and held it in 7 quarters. The position peaked at $1.75M in Q3 2015. 119 funds tracked by Wall St. Rank hold SCMP as of Q3 2016.

  • Asset Management One reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Asset Management One sold 48,532 Sucampo Pharmaceuticals, Inc. shares in Q3 2016, an estimated $532K.
  • Asset Management One first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 7 quarters.
  • Asset Management One's Sucampo Pharmaceuticals, Inc. position peaked at $1.75M in Q3 2015.
  • 119 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2016.

Based on Asset Management One's 13F filing for Q3 2016, filed 7 Nov 2016.